Transthyretin Amyloid Cardiomyopathy

A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis

EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid Cardiomyopathy

A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis.

Study of ALXN2220 Versus Placebo in Adults With ATTR-CM

Cardiac Amyloidosis in Patients With Aortic Stenosis

Bronx Transthyretin Amyloid Cardiomyopathy Database

A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India

Phenotyping and Characterization of wtATTR-CM (TRACE 1)

carDIo-ttranSSfOrm nucLEar Imaging Study

A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis

Early Diagnosis of Age-Linked CArdiac TransThyRetin Amyloidosis by Selective Screening in Spinal Stenosis Surgery

SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy

Global Prevalence of ATTR-CM in Participants With HFpEF

Dobutamine Stress Echocardiography in LF/LG Aortic Stenosis and Wild-type Transthyretin Amyloid Cardiomyopathy

Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis

Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction